Yesterday, March 21, 2016, 70 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $28.00 to $5,401,379.46. Highlighted Stocks Traded by Insiders: Flamel Technologies (FLML) - FREE Research Report Anderson Michael S, who is Chief Executive Officer at Flamel Technologies, bought 5,000 shares at $11.04 on March 21, 2016. Following this transaction, the Chief Executive Officer owned 129,250 shares meaning that the stake was boosted by 4.02% with the 5,000-share transaction. Hatten Sandra L, who is Sr. VP, Quality & Reg Affairs at Flamel Technologies, bought 3,000 shares at $11.01 on March 21, 2016. Following this transaction, the Sr. VP, Quality & Reg Affairs owned 3,000 shares meaning that the stake was boosted by 100% with the 3,000-share transaction. The shares most recently traded at $11.07, up $0.06, or 0.54% since the insider transaction. The average volume for Flamel Technologies has been 339,300 shares per day over the past 30 days. Flamel Technologies has a market cap of $435.3 million and is part of the health care sector and drugs industry. Shares are down 8.35% year-to-date as of the close of trading on Monday. Flamel Technologies SA, a specialty pharmaceutical company, develops and commercializes pharmaceutical products based on its proprietary polymer based technology primarily in the United States and Europe. The company has a P/E ratio of 11.9. Currently, there are 4 analysts who rate Flamel Technologies a buy, no analysts rate it a sell, and none rate it a hold. Exclusive Offer: Get the latest Stock Analysis on FLML - FREE TheStreet Quant Ratings rates Flamel Technologies as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and generally higher debt management risk. Get the full Flamel Technologies Ratings Report from TheStreet Quant Ratings now. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.